# Fresenius Medical Care AG: Form 20-F for the period ended Dec 31, 2021

- Company: [Fresenius Medical Care AG](/companies/fms.md) (CIK 1333141)
- Form: 20-F
- Filed: 2022-02-22
- Accepted by EDGAR: Feb 22, 2022, 13:17 ET
- Period: 2021-12-31
- Accession: 0001104659-22-025549
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1333141/000110465922025549/fms-20211231x20f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1333141/000110465922025549/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2021-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2021-01-01 to 2021-12-31 | EUR 17.62bn | ifrs-full:Revenue |
| Cost of revenue | 12 months, 2021-01-01 to 2021-12-31 | EUR 12.54bn | ifrs-full:CostOfSales |
| Gross profit | 12 months, 2021-01-01 to 2021-12-31 | EUR 5.08bn | ifrs-full:GrossProfit |
| Operating income | 12 months, 2021-01-01 to 2021-12-31 | EUR 1.85bn | ifrs-full:ProfitLossFromOperatingActivities |
| Income tax | 12 months, 2021-01-01 to 2021-12-31 | EUR 352.8m | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months, 2021-01-01 to 2021-12-31 | EUR 969.3m | ifrs-full:ProfitLossAttributableToOwnersOfParent |
| Diluted EPS | 12 months, 2021-01-01 to 2021-12-31 | EUR 3.31 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months, 2021-01-01 to 2021-12-31 | EUR 3.31 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months, 2021-01-01 to 2021-12-31 | EUR 2.49bn | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Cash and equivalents | at 2021-12-31 | EUR 1.48bn | ifrs-full:CashAndCashEquivalents |
| Current assets | at 2021-12-31 | EUR 7.97bn | ifrs-full:CurrentAssets |
| Total assets | at 2021-12-31 | EUR 34.37bn | ifrs-full:Assets |
| Current liabilities | at 2021-12-31 | EUR 7.26bn | ifrs-full:CurrentLiabilities |
| Total liabilities | at 2021-12-31 | EUR 20.39bn | ifrs-full:Liabilities |
| Shareholders' equity | at 2021-12-31 | EUR 12.70bn | ifrs-full:EquityAttributableToOwnersOfParent |
| Shares outstanding | at 2021-12-31 | 293,004,339 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1333141/000110465922025549/fms-20211231x20f.htm

Filed Feb 22, 2022.
Source: SEC EDGAR, the filing index for accession 0001104659-22-025549. Last ingested by Listed: Nov 3, 2026, 10:24 ET. No prices; not investment advice.